Sheila Kumar, M.D., M.S.

Photo of Sheila Kumar
Scientific Focus Areas: Cancer Biology, Clinical Research, Epidemiology

Publications

A selection of recent and significant publications can be viewed below.

Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.
Hassid BG, Lucas AL, Salomao M, Weng C, Liu F, Khanna LG, Kumar S, Hwang C, Chabot JA, Frucht H.
Pancreas (2014 Oct) 43:1073-7. Abstract/Full Text
BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
Lucas AL, Frado LE, Hwang C, Kumar S, Khanna LG, Levinson EJ, Chabot JA, Chung WK, Frucht H.
Cancer (2014 Jul 1) 120:1960-7. Abstract/Full Text
Response:.
Kumar S, Gunaratnam N, Ladabaum U.
Gastrointest Endosc (2014 Jun) 79:1031-2. Abstract/Full Text
Optical biopsy of sessile serrated adenomas: do these lesions resemble hyperplastic polyps under narrow-band imaging?
Kumar S, Fioritto A, Mitani A, Desai M, Gunaratnam N, Ladabaum U.
Gastrointest Endosc (2013 Dec) 78:902-909. Abstract/Full Text
High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.
Lucas AL, Shakya R, Lipsyc MD, Mitchel EB, Kumar S, Hwang C, Deng L, Devoe C, Chabot JA, Szabolcs M, Ludwig T, Chung WK, Frucht H.
Clin Cancer Res (2013 Jul 1) 19:3396-403. Abstract/Full Text
Review of the safety and efficacy of ustekinumab.
Scherl EJ, Kumar S, Warren RU.
Therap Adv Gastroenterol (2010 Sep) 3:321-8. Abstract/Full Text